Antimicrobial Agents Practice Questions

Q: What is the standard oral dose of oseltamivir for treatment?

75 mg twice daily for 5 days orally. **Explanation:** **Oseltamivir** is a neuraminidase inhibitor used for the treatment and prophylaxis of Influenza A and B. It works by preventing the release of new viral particles from infected host cells. **1. Why Option A is Correct:** The standard therapeutic dose for adults and adolescents (weighing >40 kg) is **75 mg twice daily (BID) for 5 days**. For the drug to be most effective, it must be initiated within **48 hours** of the onset of symptoms. It is administered **orally** as a prodrug (oseltamivir phosphate), which is rapidly converted by hepatic esterases into its active form, oseltamivir carboxylate. **2. Why Other Options are Incorrect:** * **Options B & D:** Oseltamivir is specifically an **oral** medication. If intravenous neuraminidase inhibition is required (e.g., in critically ill patients unable to tolerate oral meds), **Peramivir** is the drug of choice. * **Option C:** 200 mg is not a standard dose. Higher doses (e.g., 150 mg BID) have been studied for severe infections (H5N1) or immunocompromised patients, but 75 mg BID remains the gold standard for seasonal influenza. **High-Yield Clinical Pearls for NEET-PG:** * **Prophylaxis Dose:** 75 mg **once daily** for 7–10 days (post-exposure) or up to 6 weeks (during community outbreaks). * **Mechanism:** Competitive inhibition of **Neuraminidase**, preventing viral shedding. * **Pregnancy:** Oseltamivir is the preferred antiviral for pregnant women with influenza. * **Side Effects:** Most common are GI upset (nausea/vomiting); rare but serious neuropsychiatric events (confusion, self-injury) have been reported in children. * **Zanamivir:** An alternative neuraminidase inhibitor administered via **inhalation** (contraindicated in asthma/COPD due to risk of bronchospasm).

Q: What is the most important side effect of Amphotericin B?

Nephrotoxicity. **Explanation:** **Amphotericin B** is a potent polyene antifungal used for systemic fungal infections. While it has several adverse effects, **Nephrotoxicity** is the most significant and dose-limiting side effect. **1. Why Nephrotoxicity is the Correct Answer:** Amphotericin B works by binding to ergosterol in fungal cell membranes to create pores. However, it also has a partial affinity for **cholesterol** in human renal tubular cells. This leads to: * **Direct Toxicity:** Damage to the renal tubular epithelium, causing electrolyte wasting (Type 1 RTA). * **Indirect Toxicity:** Vasoconstriction of the afferent arterioles, leading to decreased Renal Blood Flow (RBF) and Glomerular Filtration Rate (GFR). This "azotemia" occurs in nearly 80% of patients treated with the conventional deoxycholate form. **2. Analysis of Incorrect Options:** * **A. Fever and Chills:** These are common **infusion-related reactions** (the "shake and bake" phenomenon). While frequent, they are transient and manageable with premedication (NSAIDs/steroids), unlike the cumulative damage of nephrotoxicity. * **C. Hyperkalemia:** This is incorrect because Amphotericin B typically causes **Hypokalemia** and **Hypomagnesemia** due to increased distal tubular permeability and wasting. * **D. Anemia:** It causes a normocytic normochromic anemia due to decreased erythropoietin production by the damaged kidneys, but it is secondary to the renal impact. **High-Yield Clinical Pearls for NEET-PG:** * **Liposomal Amphotericin B:** Developed to reduce nephrotoxicity by targeting the drug specifically to fungal cells and avoiding the kidneys. * **Saline Loading:** Administering 1 liter of normal saline before the infusion is the standard clinical practice to minimize nephrotoxicity. * **Drug of Choice:** Despite its toxicity, it remains the gold standard for **Mucormycosis** and severe **Visceral Leishmaniasis**.

Q: According to the recent classification of antitubercular drugs, which of the following drugs is classified under Group II?

Streptomycin. The classification of antitubercular drugs has been updated by the WHO to prioritize oral regimens and optimize the treatment of Drug-Resistant TB (DR-TB). **Explanation of the Correct Answer:** **Streptomycin** is classified under **Group II** (Second-line Injectable Agents). Historically, this group included Kanamycin, Capreomycin, and Amikacin. However, in the most recent WHO guidelines, Streptomycin remains the representative injectable for this category, though its use is declining in favor of all-oral regimens. **Analysis of Incorrect Options:** * **Ethambutol (Option A):** This is a **Group I** drug (First-line oral agents). Group I includes the primary "HRZE" regimen (Isoniazid, Rifampicin, Pyrazinamide, and Ethambutol). * **Levofloxacin (Option B):** This belongs to **Group A** (Fluoroquinolones) in the newer MDR-TB classification. Fluoroquinolones (Levofloxacin, Moxifloxacin) are now considered the most important components of MDR-TB treatment. * **Imipenem (Option D):** This is classified under **Group III** (or Group C in newer nomenclature), which consists of "Add-on agents" or "Other second-line agents" like Linezolid, Clofazimine, and Carbapenems. **NEET-PG High-Yield Pearls:** * **New WHO MDR-TB Classification:** * **Group A:** Fluoroquinolones (Levofloxacin, Moxifloxacin). * **Group B:** Second-line oral agents (Clofazimine, Cycloserine). * **Group C:** Add-on agents (Ethionamide, Linezolid, Bedaquiline, Delamanid). * **Bedaquiline:** Inhibits mycobacterial ATP synthase; it is a breakthrough drug for MDR-TB. * **Streptomycin Side Effect:** Ototoxicity (vestibular damage) and nephrotoxicity; it is contraindicated in pregnancy.

Q: Which of the following antibiotics can cause diabetes insipidus?

Demeclocycline. **Explanation:** **Demeclocycline** is a tetracycline derivative that acts as a specific antagonist to **Antidiuretic Hormone (ADH)** at the level of the renal collecting ducts. It inhibits the activation of adenylyl cyclase and the subsequent action of cAMP, rendering the kidneys unresponsive to ADH. This induced state of **nephrogenic diabetes insipidus** is actually utilized therapeutically to treat **SIADH** (Syndrome of Inappropriate ADH secretion)

Q: What is the drug of choice in a patient with severe complicated falciparum malaria?

Artesunate. **Explanation:** **Artesunate** is the current **Drug of Choice (DOC)** for severe or complicated *Plasmodium falciparum* malaria, as recommended by both the WHO and National Guidelines. 1. **Why Artesunate is correct:** Intravenous (IV) Artesunate is a water-soluble artemisinin derivative that acts rapidly against all erythrocytic stages of the parasite (including young rings). It clears parasitemia faster than quinine and significantly reduces mortality rates in both adults (SEAQUAMAT trial) and children (AQUAMAT trial). It also has a superior safety profile with a lower risk of hypoglycemia. 2. **Why other options are incorrect:** * **Chloroquine:** While it was once the mainstay, widespread resistance in *P. falciparum* makes it ineffective for severe cases. It is now primarily used for *P. vivax* (where sensitive). * **Quinine:** Previously the DOC, it is now considered a second-line alternative. It requires slow IV infusion, carries a high risk of **cinchonism**, and frequently causes refractory hypoglycemia due to hyperinsulinemia. * **Artemether:** This is a lipid-soluble derivative usually administered intramuscularly. Its absorption is erratic compared to the rapid bioavailability of IV Artesunate, making it less ideal for emergency stabilization. **High-Yield Clinical Pearls for NEET-PG:** * **Dosing Schedule:** IV Artesunate is given at 0, 12, and 24 hours, then once daily. * **Transition:** Once the patient can tolerate oral medication, a full 3-day course of **ACT (Artemisinin-based Combination Therapy)** must be completed. * **Side Effect:** Watch for **Post-Artesunate Delayed Hemolysis (PADH)**, which can occur 1–3 weeks after treatment. * **Pregnancy:** IV Artesunate is safe and recommended for severe malaria in **all trimesters** of pregnancy.

Q: Beta-lactam ring is present in all of the following except?

Vancomycin. **Explanation:** The core concept tested here is the structural classification of cell wall synthesis inhibitors. **Beta-lactam antibiotics** are defined by the presence of a four-membered beta-lactam ring, which is essential for their antibacterial activity as it mimics the D-Ala-D-Ala substrate of penicillin-binding proteins (PBPs). **Why Vancomycin is the correct answer:** Vancomycin is a **Glycopeptide** antibiotic, not a beta-lactam. While it also inhibits cell wall synthesis, its mechanism is distinct: it binds directly to the **D-Ala-D-Ala terminus** of the nascent peptidoglycan pentapeptide, sterically hindering polymerization (transglycosylation). It lacks the beta-lactam ring structure entirely. **Analysis of Incorrect Options:** * **Sulbactam:** This is a **Beta-lactamase inhibitor**. Although it has weak intrinsic antibacterial activity, it possesses a beta-lactam ring that allows it to act as a "suicide inhibitor" by binding irreversibly to beta-lactamase enzymes. * **Imipenem:** This belongs to the **Carbapenem** class. Carbapenems are characterized by a beta-lactam ring fused to a five-membered ring system with a carbon at position 1. * **Cephalexin:** This is a **First-generation Cephalosporin**. All cephalosporins contain a beta-lactam ring fused to a six-membered dihydrothiazine ring. **High-Yield Clinical Pearls for NEET-PG:** 1. **Beta-lactam families:** Penicillins, Cephalosporins, Monobactams (e.g., Aztreonam), Carbapenems, and Beta-lactamase inhibitors (Clavulanic acid, Sulbactam, Tazobactam). 2. **Vancomycin "Red Man Syndrome":** An infusion-related reaction caused by direct histamine release (not a true IgE-mediated allergy). 3. **Mechanism of Resistance:** The most common resistance to Vancomycin (VRSA/VRE) involves the alteration of the binding site from **D-Ala-D-Ala to D-Ala-D-Lac**.

Q: Which of the following antitubercular drug combinations is preferred in severe liver disease?

Streptomycin + Ethambutol. **Explanation:** The management of tuberculosis in patients with severe liver disease requires avoiding **hepatotoxic** drugs to prevent further hepatic injury. **1. Why Streptomycin + Ethambutol is correct:** Among the first-line anti-tubercular drugs (HRZES), **Streptomycin (S)** and **Ethambutol (E)** are the only two drugs that are **not hepatotoxic**. * **Streptomycin** is an aminoglycoside excreted primarily by the kidneys. * **Ethambutol** is an antimetabolite also primarily excreted via renal mechanisms. In cases of severe liver dysfunction (e.g., cirrhosis or acute hepatitis), the standard hepatotoxic regimen (Isoniazid, Rifampicin, and Pyrazinamide) is contraindicated. A combination of S + E (often supplemented with a fluoroquinolone) is the safest alternative. **2. Why other options are incorrect:** * **Isoniazid (H):** Highly hepatotoxic; it causes hepatitis through its metabolite, acetylhydrazine. * **Rifampicin (R):** Hepatotoxic; it causes cholestatic jaundice and induces microsomal enzymes. * **Pyrazinamide (Z):** The **most hepatotoxic** of all first-line drugs. Options A, C, and D are incorrect because they all contain at least one hepatotoxic agent (H or R), which could precipitate liver failure in a patient with pre-existing severe liver disease. **Clinical Pearls for NEET-PG:** * **Order of Hepatotoxicity:** Pyrazinamide > Isoniazid > Rifampicin. * **Safe in Liver Disease:** Streptomycin, Ethambutol, and Fluoroquinolones (like Levofloxacin). * **Safe in Renal Failure:** Rifampicin and Isoniazid (as they are metabolized by the liver). Ethambutol and Streptomycin require dose adjustment or avoidance in renal failure. * **Visual Side Effect:** Ethambutol causes optic neuritis (check visual acuity/color vision). * **Ototoxicity:** Streptomycin causes vestibulocochlear nerve damage.

Q: A patient presented with diarrhea. Stool examination shows an egg. What is the treatment of choice for this patient?

Praziquantel. ***Praziquantel*** - **Praziquantel** is the drug of choice for **tapeworm infections** (Taenia species), causing paralysis and tegument damage to the worm. - It effectively treats both **intestinal tapeworms** and **cysticercosis**, making it the most appropriate choice for Taenia eggs found in stool. *Mebendazole* - Primarily effective against **roundworms** like Ascaris, Enterobius, and hookworms, not tapeworms. - Works by inhibiting **microtubule synthesis** in nematodes but has limited efficacy against **cestodes** (tapeworms). *Albendazole* - While it has some activity against tapeworms, it's primarily used for **roundworm infections** and **hydatid cysts**. - **Praziquantel remains superior** for intestinal tapeworm infections due to better efficacy and tolerability. *Pyrantel pamoate* - Specifically targets **nematodes** (roundworms) like Ascaris and Enterobius by causing neuromuscular blockade. - Has **no activity against cestodes** (tapeworms) and would be ineffective for Taenia infections.

Q: A 25-year-old male hospitalized with a liver cyst due to Echinococcus granulosus refused surgery. Albendazole was used at a high dose for 3 months. This patient should be monitored for toxicity to which organ?

Liver. **Explanation:** **Albendazole**, a benzimidazole anthelmintic, is the drug of choice for Hydatid disease (*Echinococcus granulosus*). While short-term use (1–3 days) for intestinal worms is generally well-tolerated, **prolonged high-dose therapy** (as required for hydatid cysts or neurocysticercosis) is associated with significant systemic toxicity. 1. **Why Liver is the Correct Answer:** Albendazole undergoes extensive first-pass metabolism in the liver to its active metabolite, albendazole sulfoxide. Long-term administration frequently leads to an asymptomatic increase in **serum transaminases (ALT/AST)**. In some cases, it can cause severe hepatotoxicity or jaundice. Therefore, baseline and bi-weekly **Liver Function Tests (LFTs)** are mandatory during extended treatment cycles. 2. **Why Other Options are Incorrect:** * **Gonads:** While some animal studies suggested embryotoxicity (making it contraindicated in pregnancy), it is not typically associated with gonadal dysfunction or infertility in humans. * **Kidney:** Albendazole is not primarily nephrotoxic. Renal monitoring is not a standard requirement for this drug. * **Peripheral Nerves:** Neurotoxicity is not a side effect of albendazole. However, in neurocysticercosis, neurological symptoms may worsen due to the inflammatory response to dying parasites (managed with steroids). **NEET-PG High-Yield Pearls:** * **Mechanism of Action:** Inhibits microtubule synthesis by binding to **β-tubulin**, leading to glucose depletion and death of the parasite. * **Absorption:** Oral absorption is poor but increases significantly (up to 5x) when taken with a **fatty meal**. * **Other Major Toxicity:** **Bone marrow suppression** (leukopenia/pancytopenia) is the second most critical side effect to monitor via CBC. * **Drug of Choice:** Hydatid disease, Neurocysticercosis, Cutaneous Larva Migrans, and most intestinal nematodes (Ascaris, Hookworm, Enterobius).

Q: Combination chemotherapy is used in tuberculosis in order to reduce which of the following?

Development of drug resistance. **Explanation:** The primary rationale for using combination chemotherapy in Tuberculosis (TB) is to **prevent the development of drug resistance**. *Mycobacterium tuberculosis* undergoes spontaneous chromosomal mutations at a predictable frequency (e.g., 1 in $10^6$ bacilli for Isoniazid and 1 in $10^8$ for Rifampicin). In a typical cavitary TB lesion containing $10^9$ to $10^{12}$ bacilli, monotherapy would inevitably select for resistant mutants, leading to treatment failure. By using multiple drugs with different mechanisms of action simultaneously, the probability of a bacterium developing resistance to all drugs at once becomes mathematically negligible (e.g., $10^{-6} \times 10^{-8} = 10^{-14}$). **Analysis of Incorrect Options:** * **A. Side effects of drugs:** Combination therapy often *increases* the risk of adverse effects (e.g., additive hepatotoxicity of Isoniazid, Rifampicin, and Pyrazinamide). * **B. Cost of therapy:** Using multiple drugs is generally more expensive than using a single agent. * **C. Dosage of drugs:** In TB, drugs are used at their full therapeutic doses; combination therapy does not allow for dose reduction of individual components. **High-Yield Clinical Pearls for NEET-PG:** * **DOTS (Directly Observed Treatment Short-course):** The standard strategy to ensure compliance and prevent resistance. * **Bactericidal vs. Bacteriostatic:** Isoniazid, Rifampicin, Pyrazinamide, and Streptomycin are bactericidal; Ethambutol is primarily bacteriostatic. * **Sterilizing Effect:** Rifampicin and Pyrazinamide are the most effective at killing persistent/dormant bacilli, which helps in preventing relapse and shortening the duration of therapy. * **MDR-TB:** Defined as resistance to at least **Isoniazid and Rifampicin**.

Question 1

What is the standard oral dose of oseltamivir for treatment?

Accepted Answer

75 mg twice daily for 5 days orally

Answer

75 mg twice daily for 5 days intravenously

Answer

200 mg twice daily for 5 days orally

Answer

200 mg twice daily for 5 days intravenously

Question 2

What is the most important side effect of Amphotericin B?

Accepted Answer

Nephrotoxicity

Answer

Fever and chills

Answer

Hyperkalemia

Answer

Anemia

Question 3

According to the recent classification of antitubercular drugs, which of the following drugs is classified under Group II?

Accepted Answer

Streptomycin

Answer

Ethambutol

Answer

Levofloxacin

Answer

Imipenem

Question 4

Which of the following antibiotics can cause diabetes insipidus?

Accepted Answer

Demeclocycline

Answer

Chloramphenicol

Answer

Minocycline

Answer

Linezolid

Question 5

What is the drug of choice in a patient with severe complicated falciparum malaria?

Accepted Answer

Artesunate

Answer

Chloroquine

Answer

Quinine

Answer

Artemether

Question 6

Beta-lactam ring is present in all of the following except?

Accepted Answer

Vancomycin

Answer

Sulbactam

Answer

Imipenem

Answer

Cephalexin

Question 7

Which of the following antitubercular drug combinations is preferred in severe liver disease?

Accepted Answer

Streptomycin + Ethambutol

Answer

Streptomycin + Isoniazid

Answer

Isoniazid + Rifampicin

Answer

Rifampicin + Ethambutol

Question 8

A patient presented with diarrhea. Stool examination shows an egg. What is the treatment of choice for this patient?

Accepted Answer

Praziquantel

Answer

Mebendazole

Answer

Albendazole

Answer

Pyrantel pamoate

Question 9

A 25-year-old male hospitalized with a liver cyst due to Echinococcus granulosus refused surgery. Albendazole was used at a high dose for 3 months. This patient should be monitored for toxicity to which organ?

Accepted Answer

Liver

Answer

Gonads

Answer

Kidney

Answer

Peripheral nerves

Question 10

Combination chemotherapy is used in tuberculosis in order to reduce which of the following?

Accepted Answer

Development of drug resistance

Answer

Side effects of drugs

Answer

Cost of therapy

Answer

Dosage of drugs

Antimicrobial Agents — MCQs

Antimicrobial Agents — MCQs

On this page

Practice by Chapter

Want unlimited practice?